Blockchain Registration Transaction Record

GeoVax's GEO-CM04S1 Vaccine Shows Superior Protection in Immunocompromised Populations

GeoVax Labs, Inc. announces the effectiveness of GEO-CM04S1 vaccine in immunocompromised populations, aligning with new HHS guidelines. The vaccine offers superior protection and durability, crucial for vulnerable individuals with weakened immune systems.

GeoVax's GEO-CM04S1 Vaccine Shows Superior Protection in Immunocompromised Populations

This news showcases the importance of developing next-generation vaccines tailored to vulnerable populations, such as the immunocompromised. With the shift towards risk-based vaccine strategies, GeoVax's GEO-CM04S1 vaccine offers a promising solution for durable and broad-spectrum immunization, addressing the urgent need for effective COVID-19 protection in high-risk individuals.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x3158f4a5a2b5020a445d2450f1e3d6b07dd3ae82c89db0adbfdaea9e773beec9
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintmildWTnd-003c20357bd70a33eb743d0d592e3dfe